Search Results - "Babu, Jayachandra R."

Refine Results
  1. 1

    Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities by Neupane, Rabin, Boddu, Sai H S, Renukuntla, Jwala, Babu, R Jayachandra, Tiwari, Amit K

    Published in Pharmaceutics (13-02-2020)
    “…The transdermal route of drugs has received increased attention in recent years due to numerous advantages over the oral and injectable routes, such as…”
    Get full text
    Journal Article
  2. 2

    Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics by Dash, Ranjeet Prasad, Babu, R. Jayachandra, Srinivas, Nuggehally R.

    Published in Clinical pharmacokinetics (01-11-2018)
    “…The recent approval of edaravone has provided an intravenous option to treat amyotrophic lateral sclerosis (ALS) in addition to the existing oral agent,…”
    Get full text
    Journal Article
  3. 3

    Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine by Wang, Qi, Atluri, Keerthi, Tiwari, Amit K, Babu, R Jayachandra

    Published in Pharmaceuticals (Basel, Switzerland) (01-03-2023)
    “…Various formulations of polymeric micelles, tiny spherical structures made of polymeric materials, are currently being investigated in preclinical and clinical…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies by Dash, Ranjeet Prasad, Jayachandra Babu, R., Srinivas, Nuggehally R.

    “…The occurrence of efflux mechanisms via Permeability-glycoprotein (P-gp) recognized as an important physiological process impedes drug entry or transport…”
    Get full text
    Journal Article
  6. 6

    Resveratrol‐loaded nanomedicines for cancer applications by Annaji, Manjusha, Poudel, Ishwor, Boddu, Sai H. S., Arnold, Robert D., Tiwari, Amit K., Babu, R. Jayachandra

    Published in Cancer reports (01-06-2021)
    “…Background Resveratrol (3, 5, 4′‐trihydroxystilbene), a natural polyphenol and phytoalexin, has drawn considerable attention in the past decade due to its wide…”
    Get full text
    Journal Article
  7. 7

    Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities by Neupane, Rabin, Boddu, Sai H. S., Abou-Dahech, Mariam Sami, Bachu, Rinda Devi, Terrero, David, Babu, R. Jayachandra, Tiwari, Amit K.

    Published in Pharmaceutics (26-06-2021)
    “…Chemotherapeutic drugs are primarily administered to cancer patients via oral or parenteral routes. The use of transdermal drug delivery could potentially be a…”
    Get full text
    Journal Article
  8. 8

    Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines by Alrbyawi, Hamad, Boddu, Sai H S, Poudel, Ishwor, Annaji, Manjusha, Mita, Nur, Arnold, Robert D, Tiwari, Amit K, Babu, R Jayachandra

    “…Daunorubicin (DNR) and cardiolipin (CL) were co-delivered using thermosensitive liposomes (TSLs). 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),…”
    Get full text
    Journal Article
  9. 9
  10. 10

    pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines by Alrbyawi, Hamad, Poudel, Ishwor, Annaji, Manjusha, Boddu, Sai H S, Arnold, Robert D, Tiwari, Amit K, Babu, R Jayachandra

    Published in Pharmaceutics (26-05-2022)
    “…Daunorubicin (DNR) was delivered using a pH-sensitive liposomal system in B16-BL6 melanoma cell lines for enhanced cytotoxic effects. DNR was encapsulated…”
    Get full text
    Journal Article
  11. 11

    Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment by Kang, Xuejia, Mita, Nur, Zhou, Lang, Wu, Siqi, Yue, Zongliang, Babu, R Jayachandra, Chen, Pengyu

    Published in Pharmaceutics (20-09-2024)
    “…Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for hematological cancers, yet it faces significant hurdles,…”
    Get full text
    Journal Article
  12. 12

    Delignified wood aerogels as scaffolds coated with an oriented chitosan-cyclodextrin co-polymer for removal of microcystin-LR by Gomez-Maldonado, Diego, Reynolds, Autumn Marie, Burnett, Daniel J, Babu, R. Jayachandra, Waters, Matthew N, Peresin, Maria S

    Published in RSC advances (06-07-2022)
    “…Nano-porous aerogels are an advantageous approach to produce low-density materials with high surface area, particularly when using biobased materials…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems by Kang, Xuejia, Jadhav, Sanika, Annaji, Manjusha, Huang, Chung-Hui, Amin, Rajesh, Shen, Jianzhong, Ashby, Jr, Charles R, Tiwari, Amit K, Babu, R Jayachandra, Chen, Pengyu

    Published in Pharmaceutics (23-05-2023)
    “…Disulfiram (DSF) is a thiocarbamate based drug that has been approved for treating alcoholism for over 60 years. Preclinical studies have shown that DSF has…”
    Get full text
    Journal Article
  15. 15

    Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy by Kang, Xuejia, Huang, Yongzhuo, Wang, Huiyuan, Jadhav, Sanika, Yue, Zongliang, Tiwari, Amit K, Babu, R Jayachandra

    Published in Pharmaceutics (29-12-2023)
    “…The tumor microenvironment (TME) is pivotal in tumor growth and metastasis, aligning with the "Seed and Soil" theory. Within the TME, tumor-associated…”
    Get full text
    Journal Article
  16. 16

    Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation by Shelley, Haley, Grant, Makenzie, Smith, Forrest T., Abarca, Eva M., Jayachandra Babu, R.

    Published in AAPS PharmSciTech (01-08-2018)
    “…Nepafenac is a nonsteroidal anti-inflammatory drug (NSAID), currently only available as 0.1% ophthalmic suspension (Nevanac®). This study utilized…”
    Get full text
    Journal Article
  17. 17

    Microemulsion and Microporation Effects on the Genistein Permeation Across Dermatomed Human Skin by Chen, Li, Annaji, Manjusha, Kurapati, Sharmila, Ravis, William R., Jayachandra Babu, R.

    Published in AAPS PharmSciTech (01-11-2018)
    “…This study reports the microemulsion (ME) effects on the permeation of genistein across normal (intact) and microporated human skin. The genistein formulation…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Ligand-conjugated multiwalled carbon nanotubes for cancer targeted drug delivery by Thakur, Chanchal Kiran, Karthikeyan, Chandrabose, Ashby, Jr, Charles R, Neupane, Rabin, Singh, Vishal, Babu, R Jayachandra, Narayana Moorthy, N S Hari, Tiwari, Amit K

    Published in Frontiers in pharmacology (25-07-2024)
    “…Multiwalled carbon nanotubes (MWCNTs) are at the forefront of nanotechnology-based advancements in cancer therapy, particularly in the field of targeted drug…”
    Get full text
    Journal Article
  20. 20

    Topical Delivery of Diacetyl Boldine in a Microemulsion Formulation for Chemoprotection against Melanoma by Al Saqr, Ahmed, Annaji, Manjusha, Poudel, Ishwor, Aldawsari, Mohammed F, Alrbyawi, Hamad, Mita, Nur, Dhanasekaran, Muralikrishnan, Boddu, Sai H S, Neupane, Rabin, Tiwari, Amit K, Babu, R Jayachandra

    Published in Pharmaceutics (01-03-2023)
    “…This study aimed to develop a microemulsion formulation for topical delivery of Diacetyl Boldine (DAB) and to evaluate its cytotoxicity against melanoma cell…”
    Get full text
    Journal Article